CERE-120: Adeno-Associated Virus Delivery of Neurturin
CERE-120-09
Phase 2 mab completed
Quick answer
CERE-120: Adeno-Associated Virus Delivery of Neurturin for Idiopathic Parkinson's Disease is a Phase 2 program (mab) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Idiopathic Parkinson's Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- completed